Advocacy & News

Federal and Regulatory Outreach

AMRPA Letter of Support for Prior Authorization Reform Bill H.R. 3173

Friday, May 14, 2021

Medicare Advantage Prior Authorization

PAC Groups Joint Letter of Support for TRIA 2021

Tuesday, April 27, 2021

IMPACT Act IMPACT Act Reset

AMRPA Letter of Support for The Resetting the IMPACT Act (TRIA) of 2021

Thursday, April 15, 2021

IMPACT Act IMPACT Act Reset Post-Acute Care Reform

AMRPA & NALTH Send Joint Response to CMS on Medicare Advantage Prior Authorization Issues during the Public Health Emergency

Thursday, March 18, 2021

Regulatory Medicare Advantage Prior Authorization

AMRPA’s Comment Letter on the CMS Proposed IRF Review Choice Demonstration

Wednesday, February 17, 2021

AMRPA Second Round Comment Letter to NQF on IRF Measure Under Consideration

Tuesday, January 19, 2021

AMRPA Comment Letter to NQF on IRF Measure Under Consideration

Wednesday, January 6, 2021

AMRPA Responds to MedPAC December 2020 Session on IRF Payment Adequacy and Access

Tuesday, December 29, 2020

Regulatory Medicare Advantage #COVID19

AMRPA Submits Comments on HHS RFI on COVID-19 Regulatory Changes

Monday, December 28, 2020

Regulatory Prior Authorization IRF COVID-19

AMRPA Submits Policy Priorities & Recommendations to Biden-Harris Transition Team

Friday, December 18, 2020

Legislative Medicare Advantage Telehealth IRF COVID-19 Presidential Transition Policy

AMRPA Comments to CMS/RTI Regarding Unified PAC PPS Prototype Work

Thursday, December 17, 2020

IMPACT Act COVID-19 Unified PAC PPS

AMRPA Statement on Proposed CMS IRF Choice Review Demonstration ‎

Tuesday, December 15, 2020

AMRPA & NALTH Send Joint Letter to CMS on Medicare Advantage Prior Authorization

Wednesday, December 9, 2020

Regulatory Medicare Advantage Prior Authorization

AMRPA Submits Comment to CMS on CY 2022 Medicare Advantage and Part D Advance Notice Parts I and II

Monday, November 30, 2020

Regulatory Medicare Advantage

AMRPA Submits Comments to CMS on Medicare Care Compare Site

Thursday, November 12, 2020

AMRPA Submits comments on MCIT Pathway and Definition of "Reasonable and Necessary"

Monday, November 2, 2020

AMRPA Submits Comments on CY 2021 Medicare Physician Fee Schedule and Quality Payment Program Proposed Rule

Tuesday, October 6, 2020

Regulatory Physician Fee Schedule Quality Payment Program

DRRC Letter to HHS in Support for Federal Investment into COVID-19 Research on Disability, Independent Living and Rehabilitation

Tuesday, September 8, 2020

Regulatory COVID-19

AMRPA Letter to Congressional Leadership Regarding IMPACT Act’s Timeline & Prototype Testing

Thursday, July 30, 2020

IMPACT Act Legislative Quality

AMRPA’s Response to the CMS Proposed Rule on Inpatient Prospective Payment System for FY 2021

Friday, July 10, 2020

Regulatory IPPS/LTCH PPS

Interested in Becoming a Part of AMRPA?

AMRPA is the nation’s only trade organization dedicated solely to the interests of inpatient rehabilitation and represents more than 650 freestanding rehabilitation hospitals and rehabilitation units of general hospitals. Fill out a membership application today!